Search results
Author(s):
Rikke Esberg Kirkfeldt
,
Jens Brock Johansen
,
Jens Cosedis Nielsen
Added:
3 years ago
Cardiac implantable electronic device (CIED) therapy is effective and safe. However, infections related to CIED treatment may have devastating consequences, causing significant morbidity, mortality and generating considerable healthcare costs.1–6 Temporal trends in CIED treatment indicate a disproportional increase in CIED infections relative to implantation rates.1,7,8 Reasons for this trend are…
View more
Physicians Writing Fiction
Author(s):
Douglas P Zipes
Added:
3 years ago
Article
Author(s):
A John Camm
Added:
8 years ago
Author(s):
Žarko Calovic
Added:
8 years ago
Author(s):
Khang-Li Looi
,
Anthony SL Tang
,
Sharad Agarwal
Added:
3 years ago
Heart failure (HF) is a growing and major health burden in western countries. The prevalence of HF is estimated at 1–2 % in the western world, and the incidence approaches 5–10 per 1,000 persons per year.1Cardiac resynchronisation therapy (CRT) has been shown in multiplestudies to improve HF symptoms, quality of life and improve survivals.2–6The two landmark studies, Comparison of Medical Therapy…
View more
Author(s):
Cristian Podoleanu
,
Jean-Claude Deharo
Added:
3 years ago
The increasing use of cardiac implantable electronic devices (CIEDs) for management of cardiac conditions has over the last few years been associated with higher infection rates.1 Expanded CIED use alone cannot account for this rise,2–4 which involves both patient- and device-related factors. Indeed patients are tending to be older and presenting with co-morbidities, while devices are becoming…
View more
Author(s):
Nikolaos Fragakis
,
Gabriele Vicedomini
,
Carlo Pappone
Added:
3 years ago
Although atrial fibrillation (AF) is considered the most common arrhythmia in clinical practice, its prevalence is relatively low in the young and middle-aged, ranging from 0.5 % in men below 40 years to 1 % by 60 years.1,2 Regular exercise is proposed as a powerful tool for the primary and secondary prevention of cardiovascular disease, reducing most of the risk factors that predispose to AF,…
View more
Author(s):
Lluis Mont
,
Ivo Roca-Luque
,
Till F Althoff
Added:
2 years ago
AF Ablation in HFpEF
Author(s):
Nicolas Johner
,
Mehdi Namdar
,
Dipen Shah
Added:
1 year ago
Article
Author(s):
Marco Bergonti
Added:
1 year ago
EHRA 23 - Dr Marco Bergonti (Istituto Cardiocentro Ticino, CH) to discuss the key takeaways from the ANTWOORD II Trial.
In this study, 605 heart failure patients undergoing atrial fibrillation ablation were enrolled to receive an ANTWERP Score, which aimed to predict LVEF recovery. 70% of patients were categorised as 'responders', patients identified as those who could benefit the most from AF…
View more